Trade Summary

6 days ago, Kreitzer Anatol, serving as Chief Discovery Officer at MapLight Therapeutics, Inc. (MPLT), sold 36,284 shares at $37.09 per share, for a total transaction value of $1,345,893.62. Following this transaction, Kreitzer Anatol now holds 174,906 shares of MPLT.

This sale represents a 17.18% decrease in Kreitzer Anatol's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, July 15, 2026 and publicly disclosed via SEC Form 4 filing on Monday, July 20, 2026 at 6:00 AM ET, 5 days after the trade was made.

MapLight Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.